Upgrade to SI Premium - Free Trial

Illumina (ILMN) PT Lowered to $200 at UBS; Says May Be Time to Buy

October 6, 2015 7:44 AM
UBS analyst Jonathan Groberg lowered his price target on Illumina (NASDAQ: ILMN) to $200.00 (from $250.00) after the company's negative ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles